| __timestamp | Jazz Pharmaceuticals plc | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 406114000 | 49315000 |
| Thursday, January 1, 2015 | 449119000 | 75043000 |
| Friday, January 1, 2016 | 502892000 | 83749000 |
| Sunday, January 1, 2017 | 544156000 | 122682000 |
| Monday, January 1, 2018 | 683530000 | 207761000 |
| Tuesday, January 1, 2019 | 736942000 | 284812000 |
| Wednesday, January 1, 2020 | 854233000 | 317875000 |
| Friday, January 1, 2021 | 1451683000 | 282660000 |
| Saturday, January 1, 2022 | 1416967000 | 451421000 |
| Sunday, January 1, 2023 | 1343105000 | 481871000 |
Cracking the code
In the competitive landscape of biopharmaceuticals, effective cost management is crucial. Over the past decade, Jazz Pharmaceuticals plc and Sarepta Therapeutics, Inc. have demonstrated contrasting strategies in managing their Selling, General, and Administrative (SG&A) expenses. Jazz Pharmaceuticals has seen a steady increase in SG&A expenses, peaking in 2021 with a 258% rise from 2014 levels. This reflects their aggressive expansion and marketing strategies. Meanwhile, Sarepta Therapeutics, Inc. has shown a more conservative growth in SG&A expenses, with a notable 878% increase from 2014 to 2023, indicating a strategic focus on scaling operations. The data highlights the importance of balancing growth with cost efficiency in the biopharma sector. As these companies continue to evolve, their SG&A trends offer valuable insights into their operational priorities and market strategies.
Selling, General, and Administrative Costs: Amgen Inc. vs Jazz Pharmaceuticals plc
Operational Costs Compared: SG&A Analysis of Gilead Sciences, Inc. and Jazz Pharmaceuticals plc
Breaking Down SG&A Expenses: BeiGene, Ltd. vs Jazz Pharmaceuticals plc
United Therapeutics Corporation vs Sarepta Therapeutics, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Sarepta Therapeutics, Inc. vs ADMA Biologics, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Sarepta Therapeutics, Inc. and CRISPR Therapeutics AG
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Soleno Therapeutics, Inc.
Walgreens Boots Alliance, Inc. and Jazz Pharmaceuticals plc: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Pharming Group N.V.
Who Optimizes SG&A Costs Better? Jazz Pharmaceuticals plc or CymaBay Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Arrowhead Pharmaceuticals, Inc.
Comparing SG&A Expenses: Jazz Pharmaceuticals plc vs Vericel Corporation Trends and Insights